| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 115 | 2025 | 416 | 14.160 |
Why?
|
| Puerto Rico | 167 | 2026 | 1413 | 6.380 |
Why?
|
| Mental Disorders | 42 | 2022 | 392 | 5.230 |
Why?
|
| Child | 183 | 2025 | 3443 | 4.880 |
Why?
|
| Adolescent | 202 | 2025 | 6081 | 4.620 |
Why?
|
| Anti-Asthmatic Agents | 13 | 2025 | 44 | 2.580 |
Why?
|
| Alcohol-Related Disorders | 6 | 2019 | 63 | 2.470 |
Why?
|
| Male | 188 | 2026 | 23409 | 2.420 |
Why?
|
| Female | 192 | 2026 | 24698 | 2.390 |
Why?
|
| Alcohol Drinking | 11 | 2023 | 609 | 2.340 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 22 | 2019 | 116 | 2.310 |
Why?
|
| Humans | 251 | 2026 | 43102 | 2.280 |
Why?
|
| Depression | 15 | 2025 | 863 | 2.270 |
Why?
|
| Substance-Related Disorders | 18 | 2024 | 830 | 2.130 |
Why?
|
| Parents | 19 | 2023 | 370 | 2.080 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 14 | 2020 | 298 | 2.070 |
Why?
|
| Child, Preschool | 61 | 2024 | 1546 | 2.060 |
Why?
|
| Stress, Psychological | 19 | 2025 | 661 | 1.940 |
Why?
|
| Disasters | 6 | 2026 | 79 | 1.820 |
Why?
|
| Prevalence | 46 | 2023 | 1612 | 1.810 |
Why?
|
| Young Adult | 61 | 2025 | 5080 | 1.740 |
Why?
|
| Child Abuse | 12 | 2024 | 92 | 1.720 |
Why?
|
| Mental Health Services | 14 | 2022 | 141 | 1.670 |
Why?
|
| Longitudinal Studies | 37 | 2024 | 1063 | 1.620 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 8 | 2020 | 55 | 1.590 |
Why?
|
| Culture | 13 | 2017 | 172 | 1.440 |
Why?
|
| Adult | 80 | 2026 | 13872 | 1.410 |
Why?
|
| Family Health | 3 | 2017 | 55 | 1.410 |
Why?
|
| Antisocial Personality Disorder | 8 | 2021 | 20 | 1.380 |
Why?
|
| Alcoholism | 5 | 2019 | 305 | 1.370 |
Why?
|
| Nasal Mucosa | 8 | 2025 | 35 | 1.360 |
Why?
|
| Social Support | 7 | 2019 | 445 | 1.350 |
Why?
|
| Cyclonic Storms | 5 | 2022 | 80 | 1.340 |
Why?
|
| Anxiety Disorders | 14 | 2025 | 322 | 1.320 |
Why?
|
| New York City | 31 | 2025 | 288 | 1.300 |
Why?
|
| Sex Factors | 22 | 2025 | 1028 | 1.290 |
Why?
|
| Residence Characteristics | 9 | 2024 | 363 | 1.280 |
Why?
|
| Parent-Child Relations | 8 | 2023 | 127 | 1.170 |
Why?
|
| Cross-Cultural Comparison | 16 | 2016 | 111 | 1.150 |
Why?
|
| Genome-Wide Association Study | 18 | 2022 | 423 | 1.130 |
Why?
|
| Life Change Events | 6 | 2025 | 109 | 1.110 |
Why?
|
| School Health Services | 2 | 2025 | 90 | 1.070 |
Why?
|
| Adolescent Behavior | 10 | 2019 | 281 | 1.060 |
Why?
|
| Rhode Island | 13 | 2023 | 17 | 1.060 |
Why?
|
| Social Environment | 12 | 2019 | 218 | 1.040 |
Why?
|
| Immunoglobulin E | 15 | 2025 | 61 | 0.980 |
Why?
|
| Anxiety | 10 | 2025 | 874 | 0.980 |
Why?
|
| Hypersensitivity | 7 | 2020 | 32 | 0.940 |
Why?
|
| Family | 5 | 2020 | 195 | 0.940 |
Why?
|
| Poverty | 10 | 2024 | 400 | 0.930 |
Why?
|
| Allergens | 9 | 2024 | 65 | 0.910 |
Why?
|
| Socioeconomic Factors | 18 | 2018 | 1234 | 0.910 |
Why?
|
| Violence | 10 | 2023 | 136 | 0.900 |
Why?
|
| Acculturation | 10 | 2019 | 205 | 0.870 |
Why?
|
| Urban Population | 7 | 2025 | 374 | 0.870 |
Why?
|
| Stress Disorders, Post-Traumatic | 5 | 2023 | 568 | 0.850 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2016 | 989 | 0.840 |
Why?
|
| Middle Aged | 39 | 2026 | 12222 | 0.830 |
Why?
|
| Mental Health | 11 | 2024 | 385 | 0.810 |
Why?
|
| Risk Factors | 38 | 2022 | 3994 | 0.780 |
Why?
|
| Psychiatric Status Rating Scales | 11 | 2014 | 282 | 0.780 |
Why?
|
| Child of Impaired Parents | 5 | 2023 | 20 | 0.780 |
Why?
|
| Health Services Accessibility | 6 | 2014 | 706 | 0.770 |
Why?
|
| Suicide, Attempted | 6 | 2021 | 108 | 0.770 |
Why?
|
| Logistic Models | 20 | 2019 | 1009 | 0.750 |
Why?
|
| Health Surveys | 11 | 2012 | 405 | 0.740 |
Why?
|
| Comorbidity | 19 | 2025 | 737 | 0.740 |
Why?
|
| Depressive Disorder | 8 | 2017 | 187 | 0.730 |
Why?
|
| DNA Methylation | 11 | 2023 | 403 | 0.720 |
Why?
|
| Child Behavior Disorders | 3 | 2011 | 35 | 0.710 |
Why?
|
| Psychometrics | 11 | 2013 | 358 | 0.710 |
Why?
|
| United States | 34 | 2023 | 5205 | 0.700 |
Why?
|
| Cross-Sectional Studies | 25 | 2025 | 3156 | 0.690 |
Why?
|
| Healthcare Disparities | 3 | 2012 | 590 | 0.670 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2022 | 863 | 0.660 |
Why?
|
| Conduct Disorder | 5 | 2017 | 54 | 0.660 |
Why?
|
| Parenting | 6 | 2023 | 137 | 0.630 |
Why?
|
| Health Education | 2 | 2016 | 363 | 0.620 |
Why?
|
| Family Relations | 2 | 2018 | 46 | 0.620 |
Why?
|
| Quality of Life | 8 | 2022 | 616 | 0.600 |
Why?
|
| Prospective Studies | 18 | 2024 | 1600 | 0.600 |
Why?
|
| Twins | 3 | 2015 | 19 | 0.600 |
Why?
|
| Juvenile Delinquency | 3 | 2019 | 44 | 0.590 |
Why?
|
| Case-Control Studies | 20 | 2025 | 1285 | 0.580 |
Why?
|
| Primary Health Care | 4 | 2016 | 380 | 0.570 |
Why?
|
| Child Health Services | 3 | 2011 | 42 | 0.570 |
Why?
|
| Interviews as Topic | 11 | 2026 | 452 | 0.560 |
Why?
|
| Peer Group | 2 | 2025 | 177 | 0.560 |
Why?
|
| Protestantism | 1 | 2018 | 5 | 0.560 |
Why?
|
| Severity of Illness Index | 16 | 2018 | 719 | 0.550 |
Why?
|
| Obesity | 9 | 2025 | 1151 | 0.550 |
Why?
|
| Sex Offenses | 2 | 2022 | 45 | 0.540 |
Why?
|
| Vitamin D Deficiency | 5 | 2018 | 107 | 0.540 |
Why?
|
| Environmental Exposure | 6 | 2025 | 256 | 0.540 |
Why?
|
| Adrenal Cortex Hormones | 6 | 2024 | 64 | 0.540 |
Why?
|
| Somatoform Disorders | 2 | 2009 | 18 | 0.520 |
Why?
|
| Attitude | 1 | 2018 | 108 | 0.510 |
Why?
|
| Social Control, Informal | 1 | 2016 | 10 | 0.510 |
Why?
|
| Students | 1 | 2023 | 626 | 0.510 |
Why?
|
| Social Problems | 1 | 2016 | 14 | 0.500 |
Why?
|
| Temperament | 2 | 2015 | 36 | 0.500 |
Why?
|
| Bronchodilator Agents | 6 | 2022 | 26 | 0.480 |
Why?
|
| Medication Adherence | 3 | 2014 | 182 | 0.480 |
Why?
|
| Self Care | 2 | 2016 | 175 | 0.480 |
Why?
|
| Anxiety, Separation | 1 | 2015 | 4 | 0.460 |
Why?
|
| Internal-External Control | 3 | 2011 | 63 | 0.460 |
Why?
|
| New York | 8 | 2025 | 93 | 0.460 |
Why?
|
| Employment | 1 | 2016 | 86 | 0.450 |
Why?
|
| Age Factors | 11 | 2025 | 1154 | 0.450 |
Why?
|
| Case Management | 1 | 2014 | 24 | 0.440 |
Why?
|
| Vital Capacity | 7 | 2022 | 44 | 0.440 |
Why?
|
| Smoking | 6 | 2013 | 1024 | 0.440 |
Why?
|
| Caregivers | 7 | 2014 | 197 | 0.420 |
Why?
|
| Patient Education as Topic | 3 | 2016 | 235 | 0.420 |
Why?
|
| Interview, Psychological | 9 | 2013 | 63 | 0.420 |
Why?
|
| Social Adjustment | 3 | 2011 | 30 | 0.410 |
Why?
|
| Respiratory Function Tests | 8 | 2025 | 61 | 0.410 |
Why?
|
| Th2 Cells | 3 | 2025 | 62 | 0.410 |
Why?
|
| Complementary Therapies | 1 | 2014 | 51 | 0.400 |
Why?
|
| Drug Monitoring | 1 | 2014 | 69 | 0.400 |
Why?
|
| Medicaid | 2 | 2016 | 143 | 0.400 |
Why?
|
| Odds Ratio | 11 | 2019 | 587 | 0.380 |
Why?
|
| Hospitalization | 3 | 2020 | 485 | 0.370 |
Why?
|
| Multivariate Analysis | 11 | 2016 | 638 | 0.370 |
Why?
|
| Pilot Projects | 2 | 2025 | 760 | 0.360 |
Why?
|
| Insurance, Health | 3 | 2021 | 145 | 0.360 |
Why?
|
| Follow-Up Studies | 8 | 2022 | 1067 | 0.350 |
Why?
|
| Lung | 7 | 2022 | 492 | 0.350 |
Why?
|
| Sibling Relations | 1 | 2011 | 1 | 0.340 |
Why?
|
| Infant | 7 | 2021 | 1175 | 0.340 |
Why?
|
| Achievement | 1 | 2011 | 24 | 0.340 |
Why?
|
| Leukocytes | 4 | 2020 | 80 | 0.340 |
Why?
|
| Adaptation, Psychological | 4 | 2016 | 420 | 0.330 |
Why?
|
| Chronic Disease | 4 | 2012 | 549 | 0.330 |
Why?
|
| Sick Role | 1 | 2010 | 9 | 0.320 |
Why?
|
| Air Pollution | 3 | 2020 | 87 | 0.320 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2020 | 7 | 0.320 |
Why?
|
| Family Conflict | 1 | 2010 | 13 | 0.320 |
Why?
|
| Health Services Needs and Demand | 2 | 2010 | 154 | 0.320 |
Why?
|
| Schools | 2 | 2025 | 283 | 0.320 |
Why?
|
| Transients and Migrants | 3 | 2009 | 42 | 0.320 |
Why?
|
| Rhinitis | 2 | 2020 | 18 | 0.320 |
Why?
|
| Sexual Behavior | 4 | 2022 | 638 | 0.310 |
Why?
|
| Hypersensitivity, Immediate | 3 | 2020 | 9 | 0.310 |
Why?
|
| Adiposity | 2 | 2025 | 157 | 0.300 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 278 | 0.300 |
Why?
|
| Overweight | 2 | 2022 | 249 | 0.300 |
Why?
|
| Patient Selection | 1 | 2011 | 205 | 0.300 |
Why?
|
| Health Status Disparities | 4 | 2012 | 719 | 0.300 |
Why?
|
| Forced Expiratory Volume | 5 | 2022 | 75 | 0.300 |
Why?
|
| Cohort Studies | 12 | 2024 | 1759 | 0.290 |
Why?
|
| Cultural Diversity | 5 | 2007 | 193 | 0.290 |
Why?
|
| Drug Therapy | 1 | 2008 | 17 | 0.290 |
Why?
|
| Morbidity | 3 | 2011 | 97 | 0.290 |
Why?
|
| Perception | 1 | 2010 | 215 | 0.290 |
Why?
|
| Wounds and Injuries | 1 | 2010 | 193 | 0.290 |
Why?
|
| Self Efficacy | 3 | 2025 | 215 | 0.280 |
Why?
|
| Resilience, Psychological | 2 | 2024 | 106 | 0.280 |
Why?
|
| Quality of Health Care | 1 | 2009 | 161 | 0.270 |
Why?
|
| Personality Assessment | 6 | 2011 | 45 | 0.270 |
Why?
|
| Epidemiologic Studies | 1 | 2007 | 33 | 0.270 |
Why?
|
| Psychophysiologic Disorders | 2 | 2010 | 8 | 0.270 |
Why?
|
| Treatment Outcome | 9 | 2024 | 1604 | 0.270 |
Why?
|
| Air Pollution, Indoor | 2 | 2020 | 53 | 0.260 |
Why?
|
| Epigenesis, Genetic | 6 | 2023 | 291 | 0.260 |
Why?
|
| Community Mental Health Services | 1 | 2007 | 34 | 0.260 |
Why?
|
| Dominican Republic | 5 | 2014 | 20 | 0.260 |
Why?
|
| Diet | 4 | 2023 | 826 | 0.250 |
Why?
|
| Research Design | 3 | 2017 | 385 | 0.250 |
Why?
|
| Minority Groups | 7 | 2022 | 690 | 0.250 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2018 | 192 | 0.250 |
Why?
|
| Stress, Physiological | 2 | 2020 | 172 | 0.250 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 1081 | 0.240 |
Why?
|
| Genomics | 2 | 2019 | 293 | 0.240 |
Why?
|
| Community-Based Participatory Research | 1 | 2010 | 352 | 0.240 |
Why?
|
| Child Reactive Disorders | 1 | 2005 | 3 | 0.240 |
Why?
|
| Neurotic Disorders | 1 | 2005 | 5 | 0.240 |
Why?
|
| Emigration and Immigration | 5 | 2011 | 85 | 0.230 |
Why?
|
| Chloride Channels | 1 | 2025 | 4 | 0.230 |
Why?
|
| Dust | 3 | 2014 | 57 | 0.230 |
Why?
|
| Vitamin D | 6 | 2022 | 196 | 0.220 |
Why?
|
| Research | 1 | 2006 | 181 | 0.220 |
Why?
|
| Utilization Review | 3 | 2006 | 17 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2025 | 83 | 0.220 |
Why?
|
| Sleep | 2 | 2023 | 185 | 0.210 |
Why?
|
| Child Behavior | 2 | 2019 | 81 | 0.210 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2022 | 734 | 0.210 |
Why?
|
| Gene Expression Profiling | 6 | 2025 | 704 | 0.210 |
Why?
|
| Age of Onset | 3 | 2011 | 114 | 0.210 |
Why?
|
| Attitude of Health Personnel | 1 | 2026 | 231 | 0.210 |
Why?
|
| Health Services | 2 | 2016 | 61 | 0.210 |
Why?
|
| Emigrants and Immigrants | 2 | 2021 | 158 | 0.200 |
Why?
|
| Genotype | 4 | 2020 | 800 | 0.200 |
Why?
|
| Interleukin-13 | 1 | 2023 | 20 | 0.200 |
Why?
|
| Tobacco Use Disorder | 1 | 2007 | 250 | 0.200 |
Why?
|
| Fossil Fuels | 1 | 2023 | 2 | 0.200 |
Why?
|
| Disease Progression | 5 | 2023 | 667 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2026 | 574 | 0.200 |
Why?
|
| Health Literacy | 3 | 2023 | 130 | 0.200 |
Why?
|
| Risk-Taking | 2 | 2017 | 457 | 0.200 |
Why?
|
| Sampling Studies | 5 | 2006 | 64 | 0.200 |
Why?
|
| Health Personnel | 1 | 2026 | 277 | 0.200 |
Why?
|
| Air Pollutants | 2 | 2025 | 130 | 0.200 |
Why?
|
| Sensation | 3 | 2020 | 36 | 0.190 |
Why?
|
| Pregnancy | 5 | 2021 | 1772 | 0.190 |
Why?
|
| Adolescent Health Services | 1 | 2002 | 29 | 0.180 |
Why?
|
| Crime Victims | 1 | 2022 | 77 | 0.180 |
Why?
|
| Social Behavior | 2 | 2018 | 161 | 0.180 |
Why?
|
| Incidence | 6 | 2023 | 1078 | 0.180 |
Why?
|
| Time Factors | 4 | 2014 | 1857 | 0.180 |
Why?
|
| Aged | 14 | 2014 | 8214 | 0.180 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.170 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2020 | 53 | 0.170 |
Why?
|
| Cultural Characteristics | 3 | 2011 | 128 | 0.170 |
Why?
|
| Cultural Competency | 2 | 2014 | 138 | 0.170 |
Why?
|
| Social Values | 2 | 2011 | 31 | 0.170 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 166 | 0.170 |
Why?
|
| Administration, Inhalation | 5 | 2024 | 92 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2002 | 497 | 0.170 |
Why?
|
| Vehicle Emissions | 1 | 2020 | 22 | 0.160 |
Why?
|
| CpG Islands | 5 | 2020 | 109 | 0.160 |
Why?
|
| Nerve Net | 1 | 2021 | 101 | 0.160 |
Why?
|
| Puberty | 1 | 2020 | 31 | 0.160 |
Why?
|
| Testosterone | 1 | 2021 | 211 | 0.160 |
Why?
|
| Sulfur Dioxide | 1 | 2019 | 9 | 0.160 |
Why?
|
| Body Mass Index | 6 | 2025 | 925 | 0.160 |
Why?
|
| Spirometry | 2 | 2010 | 40 | 0.160 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 44 | 0.160 |
Why?
|
| Interferon Regulatory Factors | 1 | 2019 | 18 | 0.160 |
Why?
|
| Gambling | 1 | 2019 | 21 | 0.150 |
Why?
|
| Criminals | 1 | 2019 | 18 | 0.150 |
Why?
|
| Sexual Partners | 1 | 2022 | 326 | 0.150 |
Why?
|
| Unemployment | 3 | 2016 | 29 | 0.150 |
Why?
|
| Cytokines | 3 | 2018 | 678 | 0.150 |
Why?
|
| Homosexuality | 1 | 2019 | 36 | 0.150 |
Why?
|
| Eosinophils | 3 | 2025 | 24 | 0.150 |
Why?
|
| Estradiol | 1 | 2021 | 268 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 83 | 0.150 |
Why?
|
| Adolescent Development | 1 | 2019 | 40 | 0.150 |
Why?
|
| Mexico | 4 | 2008 | 298 | 0.150 |
Why?
|
| Universities | 1 | 2023 | 559 | 0.150 |
Why?
|
| Cuba | 3 | 2008 | 33 | 0.150 |
Why?
|
| Interleukin-17 | 2 | 2017 | 53 | 0.150 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 88 | 0.150 |
Why?
|
| Heterosexuality | 1 | 2019 | 97 | 0.140 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2015 | 4 | 0.140 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 1070 | 0.140 |
Why?
|
| Human Development | 1 | 2018 | 9 | 0.140 |
Why?
|
| Affective Symptoms | 2 | 2011 | 63 | 0.140 |
Why?
|
| Law Enforcement | 1 | 2018 | 14 | 0.140 |
Why?
|
| Interleukin-5 Receptor alpha Subunit | 1 | 2017 | 1 | 0.140 |
Why?
|
| Albuterol | 2 | 2015 | 7 | 0.140 |
Why?
|
| Population | 1 | 2017 | 8 | 0.140 |
Why?
|
| Genome, Human | 2 | 2017 | 144 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 587 | 0.130 |
Why?
|
| Cockroaches | 1 | 2017 | 8 | 0.130 |
Why?
|
| Statistics as Topic | 4 | 2016 | 123 | 0.130 |
Why?
|
| Epithelium | 3 | 2023 | 78 | 0.130 |
Why?
|
| Tropical Climate | 1 | 2017 | 23 | 0.130 |
Why?
|
| Airway Resistance | 1 | 2017 | 6 | 0.130 |
Why?
|
| Biomedical Research | 2 | 2016 | 502 | 0.130 |
Why?
|
| MicroRNAs | 1 | 2023 | 518 | 0.130 |
Why?
|
| Focus Groups | 4 | 2013 | 423 | 0.130 |
Why?
|
| Pharmacogenetics | 1 | 2017 | 67 | 0.130 |
Why?
|
| Sleep Deprivation | 1 | 2017 | 28 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 749 | 0.130 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 201 | 0.120 |
Why?
|
| Language | 3 | 2008 | 185 | 0.120 |
Why?
|
| Drug Resistance | 1 | 2017 | 96 | 0.120 |
Why?
|
| Headache | 3 | 2012 | 21 | 0.120 |
Why?
|
| Attitude to Health | 2 | 2018 | 338 | 0.120 |
Why?
|
| Maternal Exposure | 1 | 2017 | 57 | 0.120 |
Why?
|
| Chi-Square Distribution | 2 | 2014 | 236 | 0.120 |
Why?
|
| Folic Acid Deficiency | 1 | 2016 | 6 | 0.120 |
Why?
|
| Preventive Health Services | 1 | 2016 | 66 | 0.120 |
Why?
|
| Firearms | 1 | 2016 | 16 | 0.120 |
Why?
|
| Phenotype | 4 | 2025 | 780 | 0.120 |
Why?
|
| Inservice Training | 1 | 2016 | 33 | 0.120 |
Why?
|
| Weapons | 1 | 2015 | 5 | 0.120 |
Why?
|
| Counseling | 1 | 2016 | 138 | 0.120 |
Why?
|
| Nurses | 1 | 2016 | 55 | 0.120 |
Why?
|
| World Health Organization | 2 | 2013 | 36 | 0.110 |
Why?
|
| Psychiatry | 2 | 2007 | 36 | 0.110 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2015 | 27 | 0.110 |
Why?
|
| Sulfites | 1 | 2015 | 13 | 0.110 |
Why?
|
| Genetic Markers | 3 | 2023 | 150 | 0.110 |
Why?
|
| Needs Assessment | 1 | 2016 | 178 | 0.110 |
Why?
|
| Disability Evaluation | 2 | 2013 | 73 | 0.110 |
Why?
|
| Community Health Services | 1 | 2016 | 206 | 0.110 |
Why?
|
| Androstadienes | 1 | 2014 | 19 | 0.110 |
Why?
|
| Rhinitis, Allergic, Perennial | 1 | 2013 | 5 | 0.100 |
Why?
|
| Models, Biological | 1 | 2017 | 712 | 0.100 |
Why?
|
| Cyclopropanes | 1 | 2014 | 46 | 0.100 |
Why?
|
| Demography | 4 | 2007 | 195 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2024 | 2544 | 0.100 |
Why?
|
| Acetates | 1 | 2014 | 32 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2012 | 24 | 0.100 |
Why?
|
| Linear Models | 4 | 2015 | 317 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2014 | 104 | 0.100 |
Why?
|
| Physicians | 1 | 2016 | 188 | 0.100 |
Why?
|
| Sulfides | 1 | 2014 | 78 | 0.100 |
Why?
|
| Quinolines | 1 | 2014 | 78 | 0.100 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 234 | 0.100 |
Why?
|
| Object Attachment | 2 | 2011 | 28 | 0.100 |
Why?
|
| Fungi | 1 | 2014 | 106 | 0.100 |
Why?
|
| Friends | 1 | 2013 | 25 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 223 | 0.100 |
Why?
|
| Breast Feeding | 1 | 2014 | 126 | 0.100 |
Why?
|
| Models, Psychological | 2 | 2017 | 140 | 0.100 |
Why?
|
| Risk Assessment | 3 | 2020 | 863 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2012 | 310 | 0.090 |
Why?
|
| Population Groups | 2 | 2009 | 59 | 0.090 |
Why?
|
| Premature Birth | 1 | 2013 | 95 | 0.090 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 107 | 0.090 |
Why?
|
| Feeding Behavior | 1 | 2015 | 469 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2025 | 61 | 0.090 |
Why?
|
| Skin Tests | 3 | 2016 | 13 | 0.080 |
Why?
|
| Boston | 1 | 2010 | 32 | 0.080 |
Why?
|
| Prescriptions | 1 | 2010 | 19 | 0.080 |
Why?
|
| Social Perception | 1 | 2011 | 72 | 0.080 |
Why?
|
| Risk | 1 | 2011 | 287 | 0.080 |
Why?
|
| Prejudice | 1 | 2011 | 116 | 0.080 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 2 | 2008 | 44 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2010 | 9 | 0.080 |
Why?
|
| Psychopathology | 2 | 2020 | 20 | 0.080 |
Why?
|
| Psychomotor Agitation | 1 | 2010 | 8 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2013 | 430 | 0.080 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 120 | 0.080 |
Why?
|
| Maternal Welfare | 1 | 2009 | 7 | 0.080 |
Why?
|
| Brain | 1 | 2018 | 1472 | 0.080 |
Why?
|
| Impulsive Behavior | 1 | 2010 | 55 | 0.080 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 77 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2019 | 490 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 211 | 0.070 |
Why?
|
| Capacity Building | 1 | 2010 | 99 | 0.070 |
Why?
|
| Guideline Adherence | 1 | 2009 | 98 | 0.070 |
Why?
|
| Forecasting | 1 | 2009 | 136 | 0.070 |
Why?
|
| Health Status | 1 | 2012 | 442 | 0.070 |
Why?
|
| Analysis of Variance | 2 | 2013 | 575 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2010 | 359 | 0.070 |
Why?
|
| Crack Cocaine | 2 | 2004 | 8 | 0.070 |
Why?
|
| Attention | 1 | 2010 | 174 | 0.070 |
Why?
|
| Endotoxins | 2 | 2020 | 18 | 0.070 |
Why?
|
| Heroin Dependence | 2 | 2004 | 23 | 0.070 |
Why?
|
| Sweden | 2 | 2017 | 18 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2008 | 238 | 0.070 |
Why?
|
| Transcription Factors | 2 | 2023 | 735 | 0.070 |
Why?
|
| Mood Disorders | 1 | 2007 | 54 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 2 | 2004 | 102 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 1 | 2007 | 68 | 0.060 |
Why?
|
| Community Health Planning | 1 | 2006 | 38 | 0.060 |
Why?
|
| Dissociative Disorders | 1 | 2006 | 19 | 0.060 |
Why?
|
| Personnel Turnover | 1 | 2026 | 8 | 0.060 |
Why?
|
| Data Collection | 2 | 2008 | 210 | 0.060 |
Why?
|
| Siblings | 1 | 2006 | 22 | 0.060 |
Why?
|
| Burnout, Professional | 1 | 2026 | 31 | 0.060 |
Why?
|
| Syndrome | 1 | 2005 | 73 | 0.060 |
Why?
|
| Animals | 6 | 2024 | 16992 | 0.060 |
Why?
|
| Program Development | 1 | 2006 | 240 | 0.060 |
Why?
|
| Sickness Impact Profile | 1 | 2005 | 25 | 0.060 |
Why?
|
| Mothers | 1 | 2008 | 215 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2025 | 47 | 0.060 |
Why?
|
| Public Health | 2 | 2024 | 424 | 0.060 |
Why?
|
| Hospital Bed Capacity | 1 | 2024 | 5 | 0.050 |
Why?
|
| Aged, 80 and over | 2 | 2009 | 2853 | 0.050 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2004 | 22 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 31 | 0.050 |
Why?
|
| Ownership | 1 | 2024 | 12 | 0.050 |
Why?
|
| Cats | 1 | 2024 | 82 | 0.050 |
Why?
|
| Environment | 1 | 2005 | 149 | 0.050 |
Why?
|
| Urban Health | 1 | 2004 | 101 | 0.050 |
Why?
|
| Phobic Disorders | 1 | 2004 | 25 | 0.050 |
Why?
|
| Nose | 1 | 2023 | 11 | 0.050 |
Why?
|
| Dogs | 1 | 2024 | 204 | 0.050 |
Why?
|
| Hospitals | 1 | 2024 | 117 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2005 | 222 | 0.050 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2004 | 129 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 375 | 0.050 |
Why?
|
| Rural Population | 1 | 2006 | 373 | 0.050 |
Why?
|
| Registries | 2 | 2017 | 437 | 0.050 |
Why?
|
| Axonemal Dyneins | 1 | 2022 | 6 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 440 | 0.050 |
Why?
|
| Residential Treatment | 1 | 2002 | 7 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2025 | 536 | 0.050 |
Why?
|
| Hospitals, Psychiatric | 1 | 2002 | 16 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2002 | 44 | 0.050 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2021 | 25 | 0.040 |
Why?
|
| Rest | 1 | 2021 | 32 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 2 | 2013 | 162 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 180 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2021 | 65 | 0.040 |
Why?
|
| Brazil | 1 | 2021 | 84 | 0.040 |
Why?
|
| Muscle Proteins | 1 | 2021 | 51 | 0.040 |
Why?
|
| HLA-D Antigens | 1 | 2020 | 1 | 0.040 |
Why?
|
| HLA-DQ Antigens | 1 | 2020 | 6 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 207 | 0.040 |
Why?
|
| Progesterone | 1 | 2021 | 121 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 110 | 0.040 |
Why?
|
| Child Day Care Centers | 1 | 2020 | 11 | 0.040 |
Why?
|
| Family Therapy | 1 | 1980 | 24 | 0.040 |
Why?
|
| Twins, Dizygotic | 2 | 2013 | 9 | 0.040 |
Why?
|
| Twins, Monozygotic | 2 | 2013 | 10 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 206 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2023 | 666 | 0.040 |
Why?
|
| Mexican Americans | 1 | 2022 | 226 | 0.040 |
Why?
|
| Costa Rica | 1 | 2019 | 9 | 0.040 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2019 | 12 | 0.040 |
Why?
|
| Respiratory Mucosa | 1 | 2020 | 41 | 0.040 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2019 | 2 | 0.040 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2019 | 4 | 0.040 |
Why?
|
| Lectins | 1 | 2019 | 19 | 0.040 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Data Interpretation, Statistical | 1 | 2019 | 125 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2019 | 127 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2019 | 183 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 74 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 526 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2021 | 561 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2014 | 972 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2017 | 11 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 2017 | 2 | 0.030 |
Why?
|
| International Cooperation | 1 | 2017 | 52 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 86 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2021 | 561 | 0.030 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2017 | 26 | 0.030 |
Why?
|
| Computational Biology | 1 | 2019 | 327 | 0.030 |
Why?
|
| Proteomics | 1 | 2019 | 378 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2020 | 434 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 195 | 0.030 |
Why?
|
| Folic Acid | 1 | 2016 | 49 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 12 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 21 | 0.030 |
Why?
|
| Dairy Products | 1 | 2015 | 34 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 36 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2025 | 2157 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2015 | 19 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 518 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2017 | 246 | 0.030 |
Why?
|
| Mathematical Concepts | 1 | 2015 | 9 | 0.030 |
Why?
|
| Transportation | 1 | 2014 | 27 | 0.030 |
Why?
|
| Pyroglyphidae | 1 | 2014 | 5 | 0.030 |
Why?
|
| Telephone | 1 | 2014 | 36 | 0.030 |
Why?
|
| Vegetables | 1 | 2015 | 147 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 200 | 0.030 |
Why?
|
| Models, Economic | 1 | 2014 | 28 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2014 | 75 | 0.030 |
Why?
|
| Educational Status | 2 | 2007 | 339 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2013 | 34 | 0.030 |
Why?
|
| Fruit | 1 | 2015 | 178 | 0.030 |
Why?
|
| Translating | 2 | 2004 | 18 | 0.030 |
Why?
|
| Disease Management | 1 | 2014 | 70 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2013 | 90 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2015 | 456 | 0.020 |
Why?
|
| Rwanda | 1 | 2013 | 6 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2015 | 321 | 0.020 |
Why?
|
| Protein Binding | 1 | 2017 | 1082 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 179 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 76 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2013 | 134 | 0.020 |
Why?
|
| Proteins | 1 | 2015 | 382 | 0.020 |
Why?
|
| Self Concept | 1 | 2013 | 171 | 0.020 |
Why?
|
| Mice | 2 | 2014 | 6644 | 0.020 |
Why?
|
| Medical Records | 1 | 2012 | 48 | 0.020 |
Why?
|
| Cities | 1 | 2012 | 79 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2012 | 152 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 224 | 0.020 |
Why?
|
| Father-Child Relations | 1 | 2011 | 14 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 509 | 0.020 |
Why?
|
| Emotions | 1 | 2013 | 254 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2011 | 64 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 2010 | 5 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2015 | 1271 | 0.020 |
Why?
|
| Pregnancy Trimesters | 1 | 2009 | 15 | 0.020 |
Why?
|
| Social Class | 1 | 2012 | 291 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 79 | 0.020 |
Why?
|
| Language Tests | 1 | 2008 | 23 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2008 | 22 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2008 | 62 | 0.020 |
Why?
|
| Connecticut | 1 | 2007 | 11 | 0.020 |
Why?
|
| Social Conditions | 1 | 2007 | 13 | 0.020 |
Why?
|
| Psychology | 1 | 2007 | 39 | 0.020 |
Why?
|
| Latin America | 1 | 2006 | 55 | 0.020 |
Why?
|
| Multilingualism | 1 | 2007 | 52 | 0.020 |
Why?
|
| Income | 1 | 2007 | 160 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2006 | 142 | 0.010 |
Why?
|
| Exercise | 1 | 2011 | 692 | 0.010 |
Why?
|
| Domestic Violence | 1 | 2004 | 32 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 18 | 0.010 |
Why?
|
| Mass Screening | 1 | 2008 | 541 | 0.010 |
Why?
|
| Bayes Theorem | 1 | 2004 | 126 | 0.010 |
Why?
|
| Cognition | 1 | 2007 | 473 | 0.010 |
Why?
|
| Cost of Illness | 1 | 2003 | 98 | 0.010 |
Why?
|
| Decision Making | 1 | 2004 | 249 | 0.010 |
Why?
|
| Family Characteristics | 1 | 1980 | 126 | 0.010 |
Why?
|